Regarding the Filing for Approval of S-033188 in Japan Shionogi filed for approval to manufacture and sell S-033188 for the treatment of Influenza Types A and B under the priority review system of the Ministry of Health, Labor, and Welfare of Japan (“Sakigake fast-track review”)